05:33 PM, 4th Aug 2025
Glenmark Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended June 30 2025.